Connection

Eric Rovner to Aged

Back to Details
This is a "connection" page, showing publications Eric Rovner has written about Aged.
Eric Rovner
Connection Strength
1.281
Aged
  1. Is it the Surgeon? A Re-examination of Mid-urethral Sling Complications. Urology. 2021 11; 157:269-273.
    View in: PubMed
    Score: 0.062
  2. Urinary retention after AdVance? Sling: A multi-institutional retrospective study. Neurourol Urodyn. 2021 01; 40(1):515-521.
    View in: PubMed
    Score: 0.060
  3. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 02; 39(2):744-753.
    View in: PubMed
    Score: 0.056
  4. One-year results with selective bladder denervation in women with refractory overactive bladder. Neurourol Urodyn. 2019 11; 38(8):2178-2184.
    View in: PubMed
    Score: 0.054
  5. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
    View in: PubMed
    Score: 0.053
  6. Outcomes of treatment of stress urinary incontinence associated with female urethral diverticula: A selective approach. Neurourol Urodyn. 2018 01; 37(1):478-484.
    View in: PubMed
    Score: 0.047
  7. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Low Urin Tract Symptoms. 2018 Sep; 10(3):221-230.
    View in: PubMed
    Score: 0.047
  8. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8.
    View in: PubMed
    Score: 0.044
  9. Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant? Urology. 2016 Aug; 94:53-6.
    View in: PubMed
    Score: 0.043
  10. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal. J Urol. 2016 Aug; 196(2):484-9.
    View in: PubMed
    Score: 0.043
  11. Simple vs complex urethral diverticulum: presentation and outcomes. Urology. 2014 Dec; 84(6):1516-9.
    View in: PubMed
    Score: 0.039
  12. Patient perception of transvaginal mesh and the media. Urology. 2014 Sep; 84(3):575-82.
    View in: PubMed
    Score: 0.039
  13. A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol. 2013 Dec; 190(6):2243-50.
    View in: PubMed
    Score: 0.036
  14. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2013 Nov; 32(8):1109-15.
    View in: PubMed
    Score: 0.035
  15. Sling location in women with recurrent stress urinary incontinence following midurethral sling. Urology. 2012 Jan; 79(1):76-9.
    View in: PubMed
    Score: 0.032
  16. Transvaginal bladder neck closure with posterior urethral flap for devastated urethra. Urology. 2011 Jul; 78(1):208-12.
    View in: PubMed
    Score: 0.031
  17. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr; 30(4):556-62.
    View in: PubMed
    Score: 0.030
  18. Effect of A 7-F transurethral catheter on abdominal leak point pressure measurement in men with post-prostatectomy incontinence. Urology. 2011 May; 77(5):1188-93.
    View in: PubMed
    Score: 0.030
  19. Predicting for postoperative incontinence following sling incision. Int Urogynecol J. 2011 Jun; 22(6):665-9.
    View in: PubMed
    Score: 0.030
  20. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
    View in: PubMed
    Score: 0.025
  21. Complications of anterior compartment vaginal surgery. Curr Urol Rep. 2007 Sep; 8(5):405-12.
    View in: PubMed
    Score: 0.024
  22. Trospium chloride: the European experience. Expert Opin Pharmacother. 2006 Jul; 7(10):1373-80.
    View in: PubMed
    Score: 0.022
  23. Female urethral strictures: successful management with long-term clean intermittent catheterization after urethral dilatation. BJU Int. 2006 Jul; 98(1):96-9.
    View in: PubMed
    Score: 0.022
  24. Long-term chronic complications from Stamey endoscopic bladder neck suspension: a case series. Int Urogynecol J Pelvic Floor Dysfunct. 2006 May; 17(3):290-4.
    View in: PubMed
    Score: 0.020
  25. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
    View in: PubMed
    Score: 0.016
  26. Severe urinary tract damage secondary to primary bladder neck obstruction in women. PLoS One. 2021; 16(3):e0248938.
    View in: PubMed
    Score: 0.015
  27. Urinary fistula between the bladder and lower extremity following Burch urethropexy. J Urol. 2001 Feb; 165(2):525-6.
    View in: PubMed
    Score: 0.015
  28. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology. 2001 Feb; 57(2):262-5.
    View in: PubMed
    Score: 0.015
  29. Ventral hernia of the urinary bladder with mixed urinary incontinence: treatment with herniorrhaphy and allograft fascial sling. Urology. 2000 Jan; 55(1):145.
    View in: PubMed
    Score: 0.014
  30. Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). Adv Ther. 2019 08; 36(8):1906-1921.
    View in: PubMed
    Score: 0.013
  31. Extraperitoneal laparoscopic urethropexy with Marlex mesh. Urology. 1999 May; 53(5):985-9.
    View in: PubMed
    Score: 0.013
  32. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. J Urol. 2019 03; 201(3):573-580.
    View in: PubMed
    Score: 0.013
  33. Nongenomic modulation of the large conductance voltage- and Ca2+-activated K+ channels by estrogen: A novel regulatory mechanism in human detrusor smooth muscle. Physiol Rep. 2017 Jul; 5(14).
    View in: PubMed
    Score: 0.012
  34. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol. 1997 Jul; 158(1):138-41; discussion 141-2.
    View in: PubMed
    Score: 0.012
  35. Regulation of transient receptor potential melastatin 4 channel by sarcoplasmic reticulum inositol trisphosphate receptors: Role in human detrusor smooth muscle function. Channels (Austin). 2017 Sep 03; 11(5):459-466.
    View in: PubMed
    Score: 0.012
  36. BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function. Am J Physiol Renal Physiol. 2016 05 15; 310(10):F994-9.
    View in: PubMed
    Score: 0.011
  37. Novel regulatory mechanism in human urinary bladder: central role of transient receptor potential melastatin 4 channels in detrusor smooth muscle function. Am J Physiol Cell Physiol. 2016 Apr 01; 310(7):C600-11.
    View in: PubMed
    Score: 0.011
  38. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells. Pflugers Arch. 2015 Apr; 467(4):665-75.
    View in: PubMed
    Score: 0.009
  39. BRL37344, a ?3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels. Urology. 2013 Sep; 82(3):744.e1-7.
    View in: PubMed
    Score: 0.009
  40. Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels. PLoS One. 2013; 8(7):e68052.
    View in: PubMed
    Score: 0.009
  41. Single-channel biophysical and pharmacological characterizations of native human large-conductance calcium-activated potassium channels in freshly isolated detrusor smooth muscle cells. Pflugers Arch. 2013 Jul; 465(7):965-75.
    View in: PubMed
    Score: 0.009
  42. SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle. Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15; 304(2):R155-63.
    View in: PubMed
    Score: 0.009
  43. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel. Am J Physiol Renal Physiol. 2012 Nov 01; 303(9):F1300-6.
    View in: PubMed
    Score: 0.008
  44. Investigation of a Ca2+ channel a2d ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial. J Urol. 2012 Sep; 188(3):817-23.
    View in: PubMed
    Score: 0.008
  45. SK but not IK channels regulate human detrusor smooth muscle spontaneous and nerve-evoked contractions. Am J Physiol Renal Physiol. 2012 Aug 15; 303(4):F559-68.
    View in: PubMed
    Score: 0.008
  46. Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1599-608.
    View in: PubMed
    Score: 0.008
  47. Suppression of human detrusor smooth muscle excitability and contractility via pharmacological activation of large conductance Ca2+-activated K+ channels. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1632-41.
    View in: PubMed
    Score: 0.008
  48. Large-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle function. Am J Physiol Cell Physiol. 2011 Oct; 301(4):C903-12.
    View in: PubMed
    Score: 0.008
  49. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome. BJU Int. 2011 Feb; 107(4):612-20.
    View in: PubMed
    Score: 0.007
  50. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010 May; 105(9):1276-82.
    View in: PubMed
    Score: 0.007
  51. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75.
    View in: PubMed
    Score: 0.007
  52. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep; 182(3):1055-61.
    View in: PubMed
    Score: 0.007
  53. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008 May; 179(5):1850-6.
    View in: PubMed
    Score: 0.006
  54. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43.
    View in: PubMed
    Score: 0.006
  55. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007 Feb; 177(2):556-60.
    View in: PubMed
    Score: 0.006
  56. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006 Nov 15; 296(19):2319-28.
    View in: PubMed
    Score: 0.006
  57. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int. 2006 May; 97(5):1003-6.
    View in: PubMed
    Score: 0.005
  58. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
    View in: PubMed
    Score: 0.005
  59. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol. 2005 Jan; 192(1):66-73.
    View in: PubMed
    Score: 0.005
  60. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol. 2004 Dec; 172(6 Pt 1):2256-60.
    View in: PubMed
    Score: 0.005
  61. Simultaneous upper and lower urinary tract obstruction associated with severe genital prolapse: diagnosis and evaluation with magnetic resonance imaging. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(2):144-6.
    View in: PubMed
    Score: 0.004
  62. Continence mechanism based on a modified ileocecal valve. Tech Urol. 2000 Sep; 6(3):167-71.
    View in: PubMed
    Score: 0.004
  63. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res. 2000 Sep; 12 Suppl 3:S18-24.
    View in: PubMed
    Score: 0.004
  64. Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol. 2000 Jan; 163(1):87-90.
    View in: PubMed
    Score: 0.003
  65. 4-Defect repair of grade 4 cystocele. J Urol. 1999 Feb; 161(2):587-94.
    View in: PubMed
    Score: 0.003
  66. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996 Jan; 155(1):228-31.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.